Literature DB >> 2107143

Synergism between AS101 and PMA in lymphokine production.

B Sredni1, Y Kalechman, F Shalit, M Albeck.   

Abstract

AS101 [ammonium trichloro (dioxyethylene-o-o') tellurate] has been reported to stimulate normal mouse and human lymphoid cells to proliferate and to produce lymphokines such as interleukin-2 (IL-2) and colony-stimulating factor (CSF), regulators of lymphopoiesis and myelopoiesis. In this study, we demonstrate that the IL-2 secretion and cell proliferation of both human and mouse lymphocytes, and the production of CSF by mouse spleen cells, was significantly enhanced by the synergistic effect of AS101 and phorbol myristate acetate (PMA). AS101-induced activation was found to be very sensitive to inhibition by EGTA, the Ca2+ channel blocker, nifedipine, and cyclosporin A (CsA), an agent which selectively suppresses Ca2(+)-activated steps in this process. Our results suggest that AS101 may efficiently trigger the Ca2+ signal required to initiate lymphocyte activation, but that the enhancement observed when cells are stimulated with both AS101 and PMA may be due to the generation of a second signal, probably the activation of protein kinase C (PKC). A more thorough understanding of the mechanism of action of the immunomodulator AS101, presently under clinical trials on cancer and AIDS patients, is highly relevant to the assessment of its optimal application.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107143      PMCID: PMC1385728     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Calcium and lymphocyte activation.

Authors:  W C Greene; C M Parker; C W Parker
Journal:  Cell Immunol       Date:  1976-07       Impact factor: 4.868

2.  A new immunomodulating compound (AS-101) with potential therapeutic application.

Authors:  B Sredni; R R Caspi; A Klein; Y Kalechman; Y Danziger; M Ben Ya'akov; T Tamari; F Shalit; M Albeck
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

3.  Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate.

Authors:  D L Rosenstreich; S B Mizel
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

Review 4.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

5.  The interference of T cell activation by calcium channel blocking agents.

Authors:  D L Birx; M Berger; T A Fleisher
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

Review 6.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

7.  Phorbol diester receptor copurifies with protein kinase C.

Authors:  J E Niedel; L J Kuhn; G R Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  The cloning of normal "mast" cells in tissue culture.

Authors:  D H Pluznik; L Sachs
Journal:  J Cell Physiol       Date:  1965-12       Impact factor: 6.384

9.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

10.  A phorbol ester (TPA) can replace macrophages in human lymphocyte cultures stimulated with a mitogen but not with an antigen.

Authors:  G A Koretzky; R P Daniele; P C Nowell
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

View more
  1 in total

1.  Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.

Authors:  B Sredni; Y Kalechman; M Albeck; O Gross; D Aurbach; P Sharon; S N Sehgal; M J Gurwith; H Michlin
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.